ACCPL — Accretion Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapTurnaround

Annual balance sheet for Accretion Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	3.75	0.364	0.916	0.508	40.2
Net Total Accounts Receivable
Net Total Receivables	45.7	66.6	68.5	128	279
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	119	145	216	335	606
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	58.4	60.1	52.7	60.9	134
Long Term Notes Receivable
Other Long Term Assets
Total Assets	177	206	270	399	767
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	117	138	147	232	208
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	147	167	217	246	219
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	30.8	38.4	53.5	153	547
Total Liabilities & Shareholders' Equity	177	206	270	399	767
Total Common Shares Outstanding